BioELife Corp.
LITH
$0.0001
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | 0.00% | -- |
| Gross Profit | -- | -- | -- | 0.00% | -- |
| SG&A Expenses | 17.37% | 15.43% | 61.49% | -63.91% | -20.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.55% | 16.49% | 62.11% | -63.06% | -20.48% |
| Operating Income | -24.55% | -16.49% | -62.11% | 63.06% | 20.48% |
| Income Before Tax | -228.38% | -155.63% | 260.28% | -469.50% | 177.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -228.38% | -155.63% | 260.28% | -469.50% | 177.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -228.38% | -155.63% | 260.28% | -469.50% | 177.10% |
| EBIT | -24.55% | -16.49% | -62.11% | 63.06% | 20.48% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -171.33% | -154.61% | 260.21% | -441.99% | 172.59% |
| Normalized Basic EPS | 73.47% | 83.78% | 39.50% | 32.74% | 60.16% |
| EPS Diluted | -171.33% | -154.61% | 260.21% | -441.99% | 172.59% |
| Normalized Diluted EPS | 73.47% | 83.78% | 39.50% | 32.74% | 60.16% |
| Average Basic Shares Outstanding | 81.32% | 1.74% | 0.00% | 5.04% | 5.67% |
| Average Diluted Shares Outstanding | 81.32% | 1.74% | 0.00% | 5.04% | 5.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |